Today: 14 May 2026
Browse Category

Stock Market 2 May 2026

The Walt Disney Company’s ABC License Review Puts DIS Stock on Watch Before Earnings

The Walt Disney Company’s ABC License Review Puts DIS Stock on Watch Before Earnings

The FCC has ordered Disney’s ABC to file early license renewals for eight major TV stations by May 28, citing possible violations of anti-discrimination rules. FCC Chair Brendan Carr denied White House involvement and said the review concerns diversity practices, not programming. The order comes days before Disney reports quarterly results. Disney shares closed Friday at $103.08.
2 May 2026
··
Constellation Energy Stock Faces Calpine Test After Investors Reject DEI Report Bid

Constellation Energy Stock Faces Calpine Test After Investors Reject DEI Report Bid

Constellation Energy shareholders rejected a proposal to review the financial risks and returns of its DEI initiatives by 251.5 million votes to 3.0 million, SEC filings show. Investors approved all management proposals, including board nominees and executive pay. The failed DEI measure was submitted by the National Center for Public Policy Research. Constellation shares last closed at $307.81, down 1.7%.
2 May 2026
·
Bloom Energy Stock Holds Near 52-Week High as AI Power Bet Draws Fresh Scrutiny

Bloom Energy Stock Holds Near 52-Week High as AI Power Bet Draws Fresh Scrutiny

Bloom Energy shares rose $7.29 to $290.52 Friday after the company raised its 2026 forecast and announced a deal to supply up to 2.45 gigawatts of fuel-cell power to an Oracle-backed New Mexico data center. First-quarter revenue jumped 130% to $751.1 million. Options trading showed increased demand for downside protection. Plug Power and FuelCell Energy lagged, with Bloom emerging as the main fuel-cell play on AI data center growth.
2 May 2026
·····
Kraft Heinz Stock Faces New Berkshire Overhang Days Before Q1 Earnings

Kraft Heinz Stock Faces New Berkshire Overhang Days Before Q1 Earnings

Berkshire Hathaway reported its Kraft Heinz stake was $1.4 billion below carrying value at March 31 but took no new impairment. Kraft Heinz will report first-quarter results May 6, with analysts expecting earnings of 50 cents per share and $5.89 billion in revenue. Berkshire held 27.5% of Kraft Heinz as of March 31. KHC shares closed Friday at $22.49, down 0.75%.
2 May 2026
···
Fiserv Stock Gets an AI Payments Twist Before Crucial May 5 Earnings Test

Fiserv Stock Gets an AI Payments Twist Before Crucial May 5 Earnings Test

Fiserv has joined the x402 Foundation, aligning with Coinbase, Visa, Mastercard, and Stripe to develop an open standard for automated internet payments, the company said Friday. The announcement comes ahead of Fiserv’s first-quarter earnings report on May 5 and its investor day on May 14. Fiserv shares closed at $62.14, down 0.81%. Analysts expect adjusted earnings of $1.57 per share for the quarter.
2 May 2026
···
ON Semiconductor Stock Hits 52-Week High Before May 4 Earnings: Why ON Shares Are in Focus

ON Semiconductor Stock Hits 52-Week High Before May 4 Earnings: Why ON Shares Are in Focus

ON Semiconductor shares closed at a 52-week high of $103.03 on May 1, up 2.2% ahead of first-quarter earnings due May 4. The stock’s rise follows new electric-vehicle partnerships with Geely and NIO, spotlighting its silicon-carbide power chips. Analysts expect adjusted earnings of about $0.62 a share on $1.49 billion revenue. Trading volume exceeded the 50-day average.
2 May 2026
··
RTX Stock Watch: Patriot Missile Work Mounts as U.S. Fast-Tracks $8.6 Billion Arms Sales

RTX Stock Watch: Patriot Missile Work Mounts as U.S. Fast-Tracks $8.6 Billion Arms Sales

RTX Corporation was named a principal contractor in two U.S.-approved Middle East arms deals, part of over $8.6 billion in sales to Qatar, Kuwait, Israel, and the UAE. Raytheon RTX also received a $441.6 million Army contract modification for Patriot GEM-T missiles and an $833 million Navy contract for SeaSparrow missiles. RTX raised its sales outlook and dividend, but faces tariff costs and uncertain contract timing. RTX shares closed Friday at $173.99.
2 May 2026
···
Lumen Technologies (LUMN) Stock Faces May 5 Earnings Test as AI Network Bet Meets Loss Forecast

Lumen Technologies (LUMN) Stock Faces May 5 Earnings Test as AI Network Bet Meets Loss Forecast

Lumen Technologies is expected to report a first-quarter loss of 14 cents per share on May 5, with revenue projected at $2.84 billion, down 10.7% from a year ago. The quarter marks Lumen’s first results after selling its consumer fiber business to AT&T for $5.75 billion. Shares closed Friday at $9.32, up $0.475. The company will debut a new revenue reporting framework and discuss results at 5 p.m. ET.
2 May 2026
···
McDonald’s Corporation Stock Slides Before Q1 Earnings as Value Menu Faces Wall Street Test

McDonald’s Corporation Stock Slides Before Q1 Earnings as Value Menu Faces Wall Street Test

McDonald’s shares dropped 2.37% Friday, closing at $286.64 and extending losses to over 16% since early March ahead of its May 7 earnings report. Analysts expect first-quarter earnings per share of $2.75 on $6.48 billion revenue. The company will launch six specialty drinks nationwide May 6, following recent U.S. value menu promotions. Trading volume exceeded the 50-day average.
2 May 2026
··
Grab’s Indonesia Shock: Driver-Fee Cap Hits GRAB Stock Days Before Earnings

Grab’s Indonesia Shock: Driver-Fee Cap Hits GRAB Stock Days Before Earnings

Indonesia cut the maximum commission for ride-hailing platforms to 8% from 20%, directly affecting Grab and GoTo’s Gojek days before Grab’s earnings report. Drivers must now receive at least 92% of fares, and platforms are required to provide accident and health insurance. Grab and GoTo said they are reviewing the rule and will comply. Grab shares fell 3.9% to $3.67 after the announcement.
2 May 2026
··
Intel Corporation’s SambaNova AI Bet Clears U.S. Review as INTC Stock Nears $100

Intel Corporation’s SambaNova AI Bet Clears U.S. Review as INTC Stock Nears $100

U.S. antitrust regulators cleared Intel’s investment in SambaNova Systems, granting early termination for the deal and removing a key regulatory barrier. Intel raised its stake in the AI chip startup to 8.2% with a $35 million investment in February and plans another $15 million. The FTC decision does not endorse Intel’s strategy but ends the pre-closing review. Intel shares last closed at $99.62, up 5.44% on AI demand.
2 May 2026
···
US Stock Market This Week: S&P 500, Nasdaq Hit Records As Earnings Rally Faces Oil Shock Risk

US Stock Market This Week: S&P 500, Nasdaq Hit Records As Earnings Rally Faces Oil Shock Risk

The S&P 500 and Nasdaq closed at record highs Friday, lifted by strong corporate earnings, while the Dow slipped 0.3%. Apple shares rose 3.3% on a solid forecast; Atlassian surged 29.6%. Analysts expect S&P 500 first-quarter earnings to jump 27.8% from a year earlier, with 83% of companies beating profit estimates. Energy stocks lagged as Exxon Mobil and Chevron declined after weaker results.
2 May 2026
·······
Oil Prices Are High. The Bigger Shock May Still Be Ahead

Oil Prices Are High. The Bigger Shock May Still Be Ahead

Brent crude settled at $108.17 a barrel Friday, down 2%, after Iran proposed new talks with the U.S., but remained well above normal following disruptions in the Strait of Hormuz. The International Energy Agency reported global oil supply fell by 10.1 million barrels per day in March. Some physical crude grades traded near $130 a barrel. Traders are pricing in a prolonged conflict and further price spikes.
2 May 2026
·
Paramount Skydance Stock Jumps After Wall Street’s ‘Riskiest’ Upgrade as Warner Bros Deal Hits New Fight

Paramount Skydance Stock Jumps After Wall Street’s ‘Riskiest’ Upgrade as Warner Bros Deal Hits New Fight

Paramount Skydance shares rose 8.3% to $11.09 Friday after Morgan Stanley double-upgraded the stock, citing the pending $110 billion Warner Bros. Discovery takeover. The move comes ahead of Paramount’s May 4 earnings and follows a consumer lawsuit seeking to block the deal. The merger still faces regulatory review, litigation, and scrutiny over foreign investment.
2 May 2026
·
Workday Inc. Sets May 21 Earnings Date: Why Its AI Bet Faces a Crucial Test

Workday Inc. Sets May 21 Earnings Date: Why Its AI Bet Faces a Crucial Test

Workday will report fiscal 2027 first-quarter results after markets close on May 21. The company previously forecast first-quarter subscription revenue of $2.335 billion, up 13%. Shares closed Friday at $126.96, up 3.73%, amid ongoing pressure from AI competition and investor concerns over growth. CEO Aneel Bhusri returned in February as the firm pushes new AI-driven products.
2 May 2026
···
Clorox Stock Sinks After Outlook Cut: Why the Bleach Maker’s Profit Squeeze Isn’t Over

Clorox Stock Sinks After Outlook Cut: Why the Bleach Maker’s Profit Squeeze Isn’t Over

Clorox lowered its fiscal 2026 adjusted earnings forecast to $5.45–$5.65 per share, down from $5.95–$6.30, citing higher costs and slower recovery in some categories. Shares dropped 9.7% to $87.11 Friday. Net sales for the third quarter were $1.67 billion, nearly flat year-over-year. The GOJO acquisition is expected to dilute adjusted earnings by 2 to 4 cents per share.
2 May 2026
·
1 … 35 36 37 38 39 … 1,444

Stock Market Today

  • Siren Exits Ascendis Pharma with $50 Million Sale Amid Strong Quarterly Performance
    May 14, 2026, 3:43 PM EDT. On May 14, 2026, investment fund Siren sold its entire stake in Ascendis Pharma A/S, offloading 235,862 shares in a $52.87 million transaction based on first-quarter average prices. The divestment reduced Siren's position by approximately $50.3 million, including sales and market price effects. Despite this exit, Ascendis shares have risen 50% over the past year, outperforming the S&P 500 by 24 percentage points. The Danish biopharma company recently reported robust Q1 results, with revenue doubling to 247 million euros driven by sales of YORVIPATH and SKYTROFA, and recorded a net profit boosted by a deferred tax asset. Ascendis focuses on rare endocrine and pediatric diseases using its TransCon technology. Siren's sale does not signal a negative outlook amid Ascendis' strong momentum and expanding rare disease patient base.

Latest articles

REGENXBIO Stock Plunges as Duchenne Gene Therapy Win Runs Into Safety Questions

REGENXBIO Stock Plunges as Duchenne Gene Therapy Win Runs Into Safety Questions

14 May 2026
REGENXBIO shares fell 37% to $6.31 after its Duchenne muscular dystrophy gene therapy, RGX-202, met the main goal in a late-stage trial. Investors reacted to two serious adverse events and uncertainty over FDA approval. The company reported 93% of patients showed microdystrophin expression at 12 weeks. REGENXBIO said it will seek accelerated approval and targets a 2027 launch.
Digi Power X Stock Slides Before Earnings as $1.1 Billion AI Deal Faces First Test

Digi Power X Stock Slides Before Earnings as $1.1 Billion AI Deal Faces First Test

14 May 2026
Digi Power X shares fell 14% to $7.28 in heavy trading Thursday ahead of its first-quarter results and operations update due May 15. Investors are focused on its $1.1 billion, 10-year AI data-center deal with Cerebras and a $19.6 million SubQ AI GPU rental contract launching Friday. The company also expanded its at-the-market share-sale program to $175 million.
Smart Powerr Stock Nearly Quadruples as Nasdaq Delisting Threat Shadows CREG

Smart Powerr Stock Nearly Quadruples as Nasdaq Delisting Threat Shadows CREG

14 May 2026
Smart Powerr shares jumped to 78.83 cents, up nearly 59 cents from the previous close, after hitting 90.37 cents intraday. The surge followed news that Nasdaq warned the company over its sub-$1 share price and possible suspension. Trading volume reached about 395 million shares. The company said a hearing request would delay any suspension but gave no assurance of keeping its Nasdaq listing.
Go toTop